New Treatment For Renal Disease – Part 2 of 3
So, this new study included nearly 28500 advanced habitual kidney disease patients with stable high blood pressure. During a follow-up of seven months, nearly 71 percent of the patients had to begin dialysis and 20 percent died before reaching that stage. Patients who took an ACE inhibitor or an ARB had a 6 percent decrease risk of dialysis or death than those who didn’t take the drugs, according to the study published online Dec 16, 2013 in the album JAMA Internal Medicine.
And “In conclusion, our findings expand the existing knowledge in the field and provide clinicians with new information,” wrote Dr Ta-Wei Hsu, of the National Yang-Ming University Hospital, and colleagues. Dr Sripal Bangalore is an helpmate professor in the division of cardiology at NYU Langone Medical Center, in New York City. He said the scan was long needed, because this type of patient has been “largely excluded from randomized trials”.